JAK inhibitors: a potential treatment for JDM in the context of the role of interferon-driven pathology

Juvenile Idiopathic Inflammatory Myopathies (IIM) are a group of rare diseases that are heterogeneous in terms of pathology that can include proximal muscle weakness, associated skin changes and systemic involvement. Despite options for treatment, many patients continue to suffer resistant disease a...

Descripción completa

Detalles Bibliográficos
Autores principales: Ll Wilkinson, Meredyth G., Deakin, Claire T., Papadopoulou, Charalampia, Eleftheriou, Despina, Wedderburn, Lucy R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466894/
https://www.ncbi.nlm.nih.gov/pubmed/34563217
http://dx.doi.org/10.1186/s12969-021-00637-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466894/
https://www.ncbi.nlm.nih.gov/pubmed/34563217
http://dx.doi.org/10.1186/s12969-021-00637-8

Ejemplares similares